Biogen
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.
Headquarters in Cambridge, Massachusetts | |
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Company type | Public |
| |
| Industry | Biotechnology |
| Founded | 1978 |
| Founders | |
| Headquarters | Cambridge, Massachusetts, U.S. |
Key people | |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue | US$10.17 billion (2022) |
| US$3.59 billion (2022) | |
| US$2.96 billion (2022) | |
| Total assets | US$24.55 billion (2022) |
| Total equity | US$13.40 billion (2022) |
Number of employees | 8,725 (2022) |
| Website | biogen |
| Footnotes / references Financials as of December 31, 2022 | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.